Key result
ICAM-1 deficiency significantly reduced early ischemia-reperfusion damage (score 1.4 vs 2.4, P<0.05) but did not influence the size of myocardial infarction and scar formation at 1 or 3 weeks.
Why the study?
Does ICAM-1 deficiency reduce myocardial damage and scar formation after ischemia-reperfusion in mice?
Does ICAM-1 deficiency reduce myocardial damage and scar formation after ischemia-reperfusion in mice?
Absolute Event Rate: 1.4% vs 2.4%
p-value: p=<0.05
ICAM-1 deficiency reduces early ischemia-reperfusion injury but does not affect long-term infarct size or scar formation in mice.
Does not support ICAM-1 targeting to limit scar formation; leaves open its role in early reperfusion injury for further preclinical study.
OBJECTIVE: We studied the effects of temporary myocardial ischemia and reperfusion on myocyte injury and ventricular remodelling in wildtype and intercellular adhesion molecule-1- (ICAM-1) deficient mice. METHODS: ICAM-1-/- and ICAM-1+/+ mice were subjected to 30 min of myocardial ischemia and subsequent reperfusion for 2 h, 1 week and 3 weeks, respectively. The evaluation of tissue damage and scar size was performed with histological sections stained with hematoxilin and eosin. Serum levels of troponin T, creatine kinase and lactate dehydrogenase isoenzyme 1 were evaluated as an index of cardiac cellular damage. Immunohistological analysis was employed to determine cell compositions in ischemic regions. RESULTS: After myocardial ischemia (30 min) and 2 h reperfusion, elevation in serum troponin T, creatine kinase and lactate dehydrogenase isoenzyme 1 were found in both groups, but significantly reduced in ICAM-1-/- mice compared with wildtype mice (P<0.05). Absence of a functional ICAM-1 gene in ICAM-1-/- mice resulted in a marked reduction of ischemia-reperfusion injury at the early stage. The damage score and size of the infarct area were lower in ICAM-1 -/- mice by 30 min of ischemia and 2 h of reperfusion (1.4+/-0.54 vs. 2.4+/-0.47, P<0.05). The percentage of MAC-1-positive cells in the ischemic region and the border zone was also significantly diminished in groups of ICAM-1-/- mice. Surprisingly, the scar size in ventricles in animals 1 or 3 weeks after ischemia was similar between ICAM-1-/- and ICAM-1+/+ mice, although the number of infiltrated MAC-1 positive cells in the scar in wildtype mice was higher. CONCLUSION: Our results demonstrate that the absence of ICAM-1 expression results in less myocardial damage induced by ischemia-reperfusion at the early stage, but does not influence the size of myocardial infarction and scar formation.
No takes yet. Share an insight, caveat, or question.
Bernhard Metzler (2001) studied Myocardial ischemia and reperfusion injury. ICAM-1 deficiency vs. Wildtype (ICAM-1+/+) mice was evaluated on Damage score and size of the infarct area at 2 h of reperfusion (p=<0.05). ICAM-1 deficiency significantly reduced early ischemia-reperfusion damage (score 1.4 vs 2.4, P<0.05) but did not influence the size of myocardial infarction and scar formation at 1 or 3 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: